Saundra L Pelletier - Net Worth and Insider Trading
Saundra L Pelletier Net Worth
The estimated net worth of Saundra L Pelletier is at least $38 dollars as of 2025-01-12. Saundra L Pelletier is the Director of TRACON Pharmaceuticals Inc and owns about 602 shares of TRACON Pharmaceuticals Inc (TCON) stock worth over $19. Saundra L Pelletier is also the CEO of Evofem Biosciences Inc and owns about 1,894 shares of Evofem Biosciences Inc (EVFM) stock worth over $19. Details can be seen in Saundra L Pelletier's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Saundra L Pelletier has not made any transactions after 2022-05-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Saundra L Pelletier
Saundra L Pelletier Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Saundra L Pelletier owns 2 companies in total, including Evofem Biosciences Inc (EVFM) , and TRACON Pharmaceuticals Inc (TCON) .
Click here to see the complete history of Saundra L Pelletier’s form 4 insider trades.
Insider Ownership Summary of Saundra L Pelletier
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EVFM | Evofem Biosciences Inc | 2022-05-27 | director & Chief Executive Officer |
| TCON | TRACON Pharmaceuticals Inc | 2021-07-26 | director |
Saundra L Pelletier Latest Holdings Summary
Saundra L Pelletier currently owns a total of 2 stocks. Among these stocks, Saundra L Pelletier owns 602 shares of TRACON Pharmaceuticals Inc (TCON) as of July 26, 2021, with a value of $19 and a weighting of 51.08%. Saundra L Pelletier also owns 1,894 shares of Evofem Biosciences Inc (EVFM) as of May 27, 2022, with a value of $19 and a weighting of 48.92%.
Latest Holdings of Saundra L Pelletier
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCON | TRACON Pharmaceuticals Inc | 2021-07-26 | 602 | 0.03 | 19 |
| EVFM | Evofem Biosciences Inc | 2022-05-27 | 1,894 | 0.01 | 19 |
Holding Weightings of Saundra L Pelletier
Saundra L Pelletier Form 4 Trading Tracker
According to the SEC Form 4 filings, Saundra L Pelletier has made a total of 2 transactions in TRACON Pharmaceuticals Inc (TCON) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in TRACON Pharmaceuticals Inc is the acquisition of 327 shares on July 26, 2021, which cost Saundra L Pelletier around $25,002.
According to the SEC Form 4 filings, Saundra L Pelletier has made a total of 5 transactions in Evofem Biosciences Inc (EVFM) over the past 5 years, including 4 buys and 1 sells. The most-recent trade in Evofem Biosciences Inc is the acquisition of 1,128 shares on May 27, 2022, which cost Saundra L Pelletier around $49,350.
Insider Trading History of Saundra L Pelletier
- 1
Saundra L Pelletier Trading Performance
GuruFocus tracks the stock performance after each of Saundra L Pelletier's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Saundra L Pelletier is 15.9%. GuruFocus also compares Saundra L Pelletier's trading performance to market benchmark return within the same time period. The performance of stocks bought by Saundra L Pelletier within 3 months outperforms 4 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Saundra L Pelletier's insider trading performs compared to the benchmark.
Performance of Saundra L Pelletier
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 40.75 | | | | | |
| Relative Return to S&P 500(%) | 39.41 | | | | | |
Saundra L Pelletier Ownership Network
Ownership Network List of Saundra L Pelletier
Ownership Network Relation of Saundra L Pelletier
Saundra L Pelletier Owned Company Details
What does Evofem Biosciences Inc do?
Who are the key executives at Evofem Biosciences Inc?
Saundra L Pelletier is the director & Chief Executive Officer of Evofem Biosciences Inc. Other key executives at Evofem Biosciences Inc include Chief Financial Officer Yan Zhang , director & 10 percent owner Kim P. Kamdar , and Chief Commercial Officer Atkinson Katherine Cocca .
Evofem Biosciences Inc (EVFM) Insider Trades Summary
Over the past 18 months, Saundra L Pelletier made no insider transaction in Evofem Biosciences Inc (EVFM). Other recent insider transactions involving Evofem Biosciences Inc (EVFM) include a net sale of 104 shares made by Yan Zhang , and a net sale of 10 shares made by Kim P. Kamdar .
In summary, during the past 3 months, insiders sold 0 shares of Evofem Biosciences Inc (EVFM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114 shares of Evofem Biosciences Inc (EVFM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 114 shares.
Evofem Biosciences Inc (EVFM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Evofem Biosciences Inc Insider Transactions
Saundra L Pelletier Mailing Address
Above is the net worth, insider trading, and ownership report for Saundra L Pelletier. You might contact Saundra L Pelletier via mailing address: C/o Evofem Biosciences, Inc., 12400 High Bluff Drive, Suite 600, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
